Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801395 · ClinicalTrials.gov registry record
PCD New Gene Discovery
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 10
- Enrollment target
NCT03801395 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT03801395 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is a new gene discovery program for individuals with PCD who do not have a specific genetic etiology identified. Research procedures involve a single blood draw from the affected individual and from unaffected family members in an effort to identify new genetic targets.
Interventions
- OTHER There is no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-01-07 |
| Est. Completion | 2024-11-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03801395
The ClinicalTrials.gov registry entry for NCT03801395 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which There is no intervention is the first listed.
NCT03801395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03801395 about?
NCT03801395 is a clinical study titled "PCD New Gene Discovery". This is a new gene discovery program for individuals with PCD who do not have a specific genetic etiology identified. Research procedures involve a single blood draw from the affected individual and from unaffected family members in an effort to identify new genetic targets.
What is the current status of trial NCT03801395?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-01-07. Estimated completion is 2024-11-20.
What interventions are being tested in trial NCT03801395?
The interventions under investigation include: There is no intervention (OTHER).
Who is sponsoring clinical trial NCT03801395?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.